PROSPERiA
Early detection and health screenings with artificial intelligence
What it does
Mexican healthtech building AI screening products such as retinIA (automated retinal-image analysis for diabetic retinopathy and glaucoma) and evaliA; ~US$2M seed led by Cardo Health.
Best fit for
Mexican employers, clinics, and health programs looking for AI-based preventive screening and risk assessment.
Watch out for
The site does not publish pricing or a public API.
Confirmed features
Only what the vendor’s own site states. Anything not listed is unconfirmed.
Core features 3/12
- ✓LLM / generative AI agentsIt offers an intelligent assistant with LLM support.
- ✓Computer visionRetinIA analyzes retina images with AI.
- ✓Custom modelsThey say they use their own models.
Security & compliance 1/7
- ✓ISO 27001Their ISMS is aligned with ISO/IEC 27001:2013.
Customers & figures it publishes
“Founded in 2020.”
“They have training data of over 300,000 retina images.”
“A leader has implemented AI solutions benefiting more than 50 million people in 4 countries.”
As stated on the vendor’s own site; not audited by Sealbook.
Reviews
No published reviews of PROSPERiA yet. Do you use it? Be the first — your review helps other businesses decide.